Cardiac Troponin I (CTnI)/Myoglobin (MYO)/Creatine Kinase Isoenzyme (CK-MB) Rapid Test

Rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin, and creatine kinase-MB (CK-MB) markers. Designed for quick diagnosis of acute myocardial infarction and cardiac injury in clinical and emergency settings. Delivers results in minutes to support timely patient management.

A combination rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin (Myo), and creatine kinase-MB (CK-MB). This multiplex test supports cardiac biomarker assessment for heart attack and myocardial injury detection.

A multiplex rapid test cassette for simultaneous detection of cardiac biomarkers including troponin I, myoglobin, and creatine kinase-MB. The test aids in rapid cardiac assessment and myocardial infarction diagnosis at the point of care.

Multiplex rapid test for simultaneous detection of cardiac troponin I, myoglobin, and CK-MB. Comprehensive cardiac marker panel for acute coronary syndrome evaluation.

Rapid immunochromatographic assay for detection of cardiac biomarkers including troponin and myoglobin. Enables quick assessment of myocardial injury in emergency and clinical settings.

A quantitative test kit for simultaneous measurement of cardiac troponin I (cTnI), creatine kinase-MB (CK-MB), and myoglobin (MYO) levels in patient samples using TRFIA methodology.

Rapid detection of troponin and other cardiac markers for acute myocardial infarction. Enables timely diagnosis of acute coronary syndrome.

Immunofluorescence-based combined test kit for simultaneous detection of cardiac biomarkers cTnI, CK-MB, and myoglobin. Designed for rapid cardiac injury assessment in acute coronary syndrome diagnosis and risk stratification. Enables multi-marker analysis from a single sample for improved clinical decision-making.

A combination test measuring cardiac troponin I, cardiac fatty acid binding protein (H-FABP), and creatine kinase-MB (CK-MB). This multi-biomarker assay provides rapid assessment of myocardial necrosis and injury for early diagnosis of acute myocardial infarction.

Cardiac biomarker assay for detection of myocardial infarction and acute coronary syndrome. Supports rapid cardiac risk stratification in emergency settings.

Diagnostic test for high-sensitivity cardiac troponin I (Hs-cTnI) and other cardiac markers. Provides rapid assessment for acute coronary syndrome evaluation.

High-sensitivity fluorescence immunoassay panels for cTnI, NT-proBNP, D-Dimer, CK-MB, and Myoglobin designed for point-of-care use in chest pain units, emergency departments, and remote healthcare settings. Provides quantitative limit ≤ 0.1 ng/mL for critical decision making with results in 8–15 minutes from whole blood. Reader-compatible for quantitative reporting and clinically validated against central laboratory methods.